Company Analysis

Medicinova Inc (MNOV)

Nasdaq: MNOV · Pharmaceutical Preparations · La Jolla, CA · filing with the SEC since 2003
Grade5.6
◀ Past 4.8● Present 6.8▶ Future 5.0
2 est.

Who runs Medicinova Inc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Iwaki Yuichi
President and CEO. First filing Jan 2006, latest Jan 20, 2026, 1 filing in all.
Officers reporting now
2
of 5 people with a filing in the last fifteen months
Directors reporting now
3
15 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Iwaki YuichiPresident and CEOJan 2006Jan 20, 2026none
Matsuda KazukoChief Medical OfficerSep 2011Jan 20, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Beaver CarolyndirectorOct 2020Jun 25, 2026none
Lemerond NicoledirectorAug 2023Jun 25, 2026none
Nagao HidekidirectorJan 2006Jun 25, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
3d Investment Partners Pte. Ltd.10% ownerJan 2021Sep 29, 2026none
3d Opportunity Master Fund10% ownerJan 2021Sep 29, 20261 · $1.7M
Earlier names on the record10, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MNOV · research, not advice